Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2B6 | P20813 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL949321 | 0.79 | CYP2B6 (0.35) | CYP2B6 | |
| SCHEMBL946281 | 0.79 | CYP2B6 (0.35) | CYP2B6 | |
| SCHEMBL1427314 | 0.74 | CYP2B6 (0.35) | CYP2B6 | |
| SCHEMBL3232963 | 0.74 | CYP2B6 (0.35) | CYP2B6 | |
| SCHEMBL2285285 | 0.74 | CYP2B6 (0.35) | CYP2B6 | |
| SCHEMBL3007493 | 0.70 | CTSL (0.35) | CYP2B6 | |
| SCHEMBL6783509 | 0.70 | HRH3 (0.34) | CYP2B6 | |
| SCHEMBL14206026 | 0.70 | CYP2B6 (0.33) | CYP2B6 | |
| SCHEMBL5243915 | 0.69 | CYP2B6 (0.39) | CYP2B6 | |
| SCHEMBL946474 | 0.69 | TSHR (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3558235-B1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | OREAL (FR) | 2021-09-08 | — | — | EP | claimed |
| EP-3638200-A1 | PROCESS FOR DYEING KERATIN MATERIALS USING AT LEAST ONE BLUE, PURPLE OR GREEN DYE AND AT LEAST ONE DISULFIDE, THIOL OR PROTECTED THIOL FLUORESCENT DYE | L'Oreal (FR) | 2020-04-22 | — | — | EP | claimed |
| EP-3558235-A1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | L'Oréal (FR) | 2019-10-30 | — | — | EP | claimed |
| WO-2018229296-A1 | PROCESS FOR DYEING KERATIN MATERIALS USING AT LEAST ONE BLUE, PURPLE OR GREEN DYE AND AT LEAST ONE DISULFIDE, THIOL OR PROTECTED THIOL FLUORESCENT DYE | L'OREAL (FR) | 2018-12-20 | — | — | WO | claimed |
| WO-2018115337-A1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | L'OREAL (FR) | 2018-06-28 | — | — | WO | claimed |
| US-20230240954-A1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | L'OREAL (FR) | 2023-08-03 | — | — | US | disclosed |
| US-11278482-B2 | Process for dyeing keratin materials using at least one blue, purple or green dye and at least one disulfide, thiol or protected thiol fluorescent dye | L'OREAL (FR) | 2022-03-22 | — | — | US | disclosed |
| EP-3558235-B1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | OREAL (FR) | 2021-09-08 | — | — | EP | disclosed |
| US-20200179255-A1 | PROCESS FOR DYEING KERATIN MATERIALS USING AT LEAST ONE BLUE, PURPLE OR GREEN DYE AND AT LEAST ONE DISULFIDE, THIOL OR PROTECTED THIOL FLUORESCENT DYE | L'OREAL (FR) | 2020-06-11 | — | — | US | disclosed |
| EP-3638200-A1 | PROCESS FOR DYEING KERATIN MATERIALS USING AT LEAST ONE BLUE, PURPLE OR GREEN DYE AND AT LEAST ONE DISULFIDE, THIOL OR PROTECTED THIOL FLUORESCENT DYE | L'Oreal (FR) | 2020-04-22 | — | — | EP | disclosed |
| EP-3558235-A1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | L'Oréal (FR) | 2019-10-30 | — | — | EP | disclosed |
| WO-2018229296-A1 | PROCESS FOR DYEING KERATIN MATERIALS USING AT LEAST ONE BLUE, PURPLE OR GREEN DYE AND AT LEAST ONE DISULFIDE, THIOL OR PROTECTED THIOL FLUORESCENT DYE | L'OREAL (FR) | 2018-12-20 | — | — | WO | disclosed |
| US-9115165-B2 | Tetracyclic anthraquinone antibiotic derivatives with high activity, process for preparing the same and use thereof | TIANJIN HEMAY BIO-TECH CO., LTD. (CN) | 2015-08-25 | — | — | US | disclosed |
| CN-102690309-A | Floxuridine compound and preparation method and application thereof | UNIV PLA 2ND MILITARY MEDICAL | 2012-09-26 | — | — | CN | disclosed |
| CN-102558263-A | Doxifluridine derivative and preparation method and pharmaceutical application thereof | SHANGHAI RUIGUANG BIOCHEMICAL SCI TECH DEV CO LTD | 2012-07-11 | — | — | CN | disclosed |
| US-20110224161-A1 | TETRACYCLIC ANTHRAQUINONE ANTIBIOTIC DERIVATIVES WITH HIGH ACTIVITY, PROCESS FOR PREPARING THE SAME AND USE THEREOF | TIANJIN HEMAY BIO-TECH CO., LTD. (CN) | 2011-09-15 | — | — | US | disclosed |
| CN-1931869-B | Derivative of 5-deoxy-5-fluoro cytidine and its preparation process and use | SHANGHAI RUIGUANG BIOCHEMICAL TECHNOLOGY DEV CO LTD | 2011-05-11 | — | — | CN | disclosed |
| EP-2277884-A1 | ANTHRACYCLINE ANTIBIOTIC DERIVATIVES WITH HIGH ACTIVITY, PREPARATION METHODS AND USES THEREOF | Tianjin Hemay Bio-Tech Co., Ltd. (CN) | 2011-01-26 | — | — | EP | disclosed |
| CN-101759720-A | Acyclic nucleoside phosphonate compounds or pharmaceutically acceptable salts thereof, preparation method, application, intermediate compounds thereof, and medicinal composition containing same | SHANGHAI SINCH PHARMACEUTICALS | 2010-06-30 | — | — | CN | disclosed |
| CN-1931869-A | Derivative of 5-deoxy-5-fluoro cytidine and its prepn process and use | UNIV PLA 2ND MILITARY MEDICAL (CN) | 2007-03-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224161-A1 | TETRACYCLIC ANTHRAQUINONE ANTIBIOTIC DERIVATIVES WITH HIGH ACTIVITY, PROCESS FOR PREPARING THE SAME AND USE THEREOF | DHPS, TBCA, ANTXR2 | CYP2B6 138/4885 |
| US-20230240954-A1 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | KRT18, CUTA, KLK5 | CYP2B6 424/4885 |
| US-20200179255-A1 | PROCESS FOR DYEING KERATIN MATERIALS USING AT LEAST ONE BLUE, PURPLE OR GREEN DYE AND AT LEAST ONE DISULFIDE, THIOL OR PROTECTED THIOL FLUORESCENT DYE | KRT18, IK, CUTA | CYP2B6 1179/4885 |
| US-11278482-B2 | Process for dyeing keratin materials using at least one blue, purple or green dye and at least one disulfide, thiol or protected thiol fluorescent dye | KRT18, IK, CUTA | CYP2B6 1179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.